How many drugs treat Inflammatory dermatosis?

Drug Landscape tracks 4 marketed treatments for Inflammatory dermatosis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/inflammatory-dermatosis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Inflammatory dermatosis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inflammatory dermatosis (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Inflammatory dermatosis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Temovate	CLOBETASOL PROPIONATE	Fougera Pharms	Corticosteroid	Glucocorticoid receptor	1985-01-01
Cortef	hydrocortisone	Generic (originally Merck/Upjohn)	Corticosteroid [EPC]	Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible	1952-01-01
Cortifoam	HYDROCORTISONE ACETATE	Pfizer	Corticosteroid	Corticosteroid-binding globulin	1951-01-01
Cortisol	Cortisol	University of Zurich		Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Inflammatory dermatosis
Fougera Pharms · 1 drug in Inflammatory dermatosis
Generic (originally Merck/Upjohn) · 1 drug in Inflammatory dermatosis
Pfizer · 1 drug in Inflammatory dermatosis
University of Zurich · 1 drug in Inflammatory dermatosis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Inflammatory dermatosis:

Cite this brief

Drug Landscape (2026). Inflammatory dermatosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/inflammatory-dermatosis. Accessed 2026-06-10.

Inflammatory dermatosis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing